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Mtmr8 is essential for vasculature development
in zebrafish embryos
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Abstract
Background: Embryonic morphogenesis of vascular and muscular systems is tightly coordinated, and a functional
cooperation of Mtmr8 with PI3K in actin filament modeling and muscle development has been revealed in
zebrafish. Here, we attempt to explore the function of Mtmr8 in vasculature development parallel to its function in
muscle development.
Results: During early stage of somitogenesis, mtmr8 expression was detected in both somitic mesodem and
ventral mesoderm. Knockdown of mtmr8 by morpholino impairs arterial endothelial marker expression, and results
in endothelial cell reduction and vasculogenesis defects, such as retardation in intersegmental vessel development
and interruption of trunk dorsal aorta. Moreover, mtmr8 morphants show loss of arterial endothelial cell identity in
dorsal aorta, which is effectively rescued by low concentration of PI3K inhibitor, and by over-expression of dnPKA
mRNA or vegf mRNA. Interestingly, mtmr8 expression is up-regulated when zebrafish embryos are treated with
specific inhibitor of Hedgehog pathway that abolishes arterial marker expression.
Conclusion: These data indicate that Mtmr8 is essential for vasculature development in zebrafish embryos, and
may play a role in arterial specification through repressing PI3K activity. It is suggested that Mtmr8 should
represent a novel element of the Hedgehog/PI3K/VEGF signaling cascade that controls arterial specification.
Background
MTM (myotubularin myopathy) family factors are mem-
bers of the growing class of dual-specificity phosphatases
(DSPs) including PTEN, which can dephosphorylate the
products of phosphoinositide 3-kinases (PI3K), and are
negative regulators of the PI3K/Akt signaling pathways
[1]. A potential function for PI3K and PTEN has been
suggested in both angiogenic signaling[2,3] and various
models of muscle defects[4]. And, dual-specific phospha-
tase-5 (Dusp-5) has been identified to play a functional
role in vascular development through counteracting the
function of Snrk-1, a serine threonine kinase in angio-
blast development[5]. However, functions of MTM
family members in these processes are not clear.
In vertebrates, vascular and muscular systems are
tightly connected. And, the cells in dorsal aorta and
myotomal muscle are both derived from mesoderm.
Endothelial cells (ECs) forming intersegmental vessel
(SE) migrate following a path initially along the somite
boundary and later between notochord and somitic
tissue[6]. These data suggested that a dynamic connec-
tion between somitogenesis and vasculature develop-
ment might exist, and the connection might be
influenced by some signaling molecules. For example,
semaphorin-plexin-signaling was proved to play signifi-
cant roles in both somitogenesis and vasculature forma-
tion in zebrafish[6]. Furthermore, zebrafish perlecan was
demonstrated to play a central function in skeletal mus-
cle and cardiovascular development[7].
Several signaling pathways, such as vascular endothe-
lial growth factor (VEGF) signaling, and PI3K/Akt and
Hedgehog (Hh) signaling which genetically interacts
with each other[8-10], had been shown to be involved in
vascular formation. In vitro studies suggested a role for
AKT/PKB as a downstream effector of VEGF signaling
[11,12]. Moreover, over-expression of the downstream
effector AKT/PKB rescued VEGF receptor blockade[13].
In addition, activation of protein kinase A (PKA),
a negative regulator of hedgehog pathway, effectively
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inhibited Akt, which demonstrated a direct role for AKT
in regulating Hedgehog signaling[13,14]. Myocardial Hh
activation triggered by FGF signaling, is essential for
Vegf expression[15]. However, these signaling interac-
tions form complicated network and need further
explanation.
Specific genes controlling artery/vein specification have
been identified in different vertebrate species[16]. In zeb-
rafish embryo, sonic hedgehog (Shh) and Vegf, expressed
in the notochord and somite respectively, are required
for arterial specification[9,17]. Conversely, activation of
PI3K/AKT signaling in angioblasts promotes venous spe-
cification[18]. However, the precise mechanism of signal-
ing interactions in vascular development remains to be
elucidated. Interestingly, our recent study has shown a
functional cooperation of the MTM family member
Mtmr8 with PI3K in muscle development in zebrafish,
and revealed a possible participation of Mtmr8 in the
Hedgehog (Hh) pathway[19]. To explore the function of
Mtmr8 in vasculature development, here, we further
observed the vascular development defects of Mtmr8
loss-of-function. Subsequently, we found that the Mtmr8,
as a negative regulator of PI3K, affected the Hedgehog
and Vegf pathway in the blood vessel development
in vivo. The data indicate that Mtmr8 is essential for
vasculature development in zebrafish.
Results
Developmental defects of hemato-vascular progenitors in
mtmr8 morphants
During zebrafish somitogenesis, mtmr8 transcript was
detected in early somitic mesoderm between 1-13
somites, and later in ventral mesoderm[19], where mul-
tipotential progenitors gives rise to at least two different
tissues: the hematopoietic and endothelial lineages[20].
In order to reveal further functions of Mtmr8, we ana-
lyzed the expression pattern of some known early mar-
ker genes for hemato-vascular progenitors in lateral
mesoderm of mtmr8 morphants by in situ hybridization.
As shown in Figure 1, the early angioblast/hematopoie-
tic mesoderm marker genes, scl and hbae1, are
expressed in anterior lateral mesoderm (ALM) and/or
posterior lateral mesoderm (PLM) in Cont-MO injected
embryos (Figure 1A, C), whereas at the same embryonic
stage of 12 somites, significant expression reduction is
observed in mtmr8 morphants (Figure 1B, D). And,
Mtmr8 knockdown simultaneously affects the formation
of somitic mesoderm, because myod expression is signif-
icantly reduced in mtmr8 morphants in comparison to
Cont-MO embryos (Figure 1E, F). As Scl was demon-
strated to be very critical for zebrafish endothelial and
artery development[21], we further assayed expression
of fli1, a marker for endothelial cells and also for a sub-
set of the hematopoietic cells in early development stage
[22]. Compared to Cont-MO embryos (Figure 1G), fli1
is also significantly reduced in anterior lateral mesoderm
(ALM) of the mtmr8 morphants, whereas its expression
defect is mild in posterior lateral mesoderm (PLM) (Fig-
ure 1H). Moreover, the expression differences of these
marker genes were confirmed by quantitative RT-PCR.
As shown in Figure 1I, the expression levels of scl,
hbae1, myod, and fli1 are greatly reduced to 45.8%,
24.8%, 9.0%, and 51.9% of the control embryos. The
data indicate that Mtmr8 knockdown affects endothelial
cell formation and results in developmental defects of
hemato-vascular progenitors.
Determination of abnormal vascular phenotypes in
mtmr8 morphant embryos
Previous study has observed that mtmr8 is expressed
predominantly in the vasculature around and after
24 hpf[19]. To determine whether Mtmr8 is required
Figure 1 Early marker genes for hemato-vascular progenitors,
such as early angioblast/hematopoietic mesoderm marker
genes scl (A, B) and hbae1(C, D), somitic mesoderm marker
gene myod(E, F), and endothelial cell marker gene fli1(G, H),
are affected in lateral mesoderm of mtmr8 knockdown
embryos during somitogenesis. All pictures were taken from 12
somites stage embryos. Panels are flat-mounted dorsal views
(anterior toward the left). ALM (anterior lateral mesoderm) and PLM
(posterior lateral mesoderm) are indicated by arrows. (I) Percentages
of scl, hbae1, myod and fli1 expression of mtmr8 morphant embryos
relative to Cont-MO embryos revealed by Q-RT-PCR. * indicates
significance of p < 0.05.
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for vasculogenesis and angiogenesis, transgenic Tg(kdrl:
GFP)la116[23] embryos were injected with morpholino
against mtmr8 as described previously[19], and their
vasculature development was assayed. As shown in Fig-
ure 2, in comparison with normal vasculature pheno-
types in Cont-MO embryos (Figure 2A), the primary
intersegmental vessel (Se)[24] and dorsal longitudinal
anastomotic vessel (DLAV) can sprout and form, but
intensive defects are observed in mtmr8-MO morphants
at 48 hpf. The vascular plexus in tail seems to be less
complex and becomes narrow. Significantly, the mtmr8
morphants display a remarkable reduction in the size of
dorsal aorta (DA), and the DA size reduction degree is
correlated with severity of the impaired Se (Figure 2B).
The defected embryos are divided into three kinds
according to relative normal Se number. The severely
defected embryos with less than 5 normal Se and mild
defected embryos with more than 5 normal Se in the
trunk are 71.6% and 23.9% respectively, whereas normal
phenotype is only 4.5% (Figure 2J). To demonstrate the
defected specificity, we co-injected 100 pg of zebrafish
mtmr8 mRNA with the MO, and thereby led to an
increase percentage of embryos in mild (69.7%) and nor-
mal (18.1%) phenotypes (Figure 2C, J). And, we co-
injected a mis-match mtmr8 mRNA which is unable to
bind MO because of the existence of nucleotide substi-
tutions but still encodes the same protein, with the MO,
and could also rescue the morphant (Figure 2J). Pre-
vious study observed that the expression of ptc1, a
downstream target gene of the Hedgehog signaling path-
way, was reduced in mtmr8 morphants, which could be
rescued by co-injection with dnPKA mRNA[19]. And,
the Hedgehog signaling pathway was shown to be essen-
tial for vasculture differentiation and to induce the
expression of Vegf during the same process[9]. Consis-
tently, the vascular defect of mtmr8 morphants could be
rescued by co-injection of 100 pg dnPKA mRNA (Figure
2D, J). And, scl overexpression could partially rescue the
vascular defect of mtmr8 morphants, even though the
defect reduction was very small (Figure 2J). Moreover,
HE stained longitudinal and transverse sections were
analyzed. In comparison with that of Cont-MO embryos
(Figure 2E, G), the DA appears more narrow in the
mtmr8 morphants (Figure 2F, H, I). These data indicate
that Mtmr8 is essential for the integrity of muscle and
vasculature development, and that hedgehog pathway
mediates these biological activities.
To clarify what stage of vasculogenesis is affected, we
further observed blood circulation and vascular pheno-
types in early morphant embryos. The movies at same
stages of 28 hpf (Additional files 1) and 36 hpf (Addi-
tional files 2) reveal significant difference of blood cell
circulation between normal control embryos and mor-
phant embryos. In Cont-MO embryos, blood cells
normally circulate in the trunk vessels, whereas almost
no any blood cells flow in that of 28 hpf morphant
embryos (Additional files 1), and only a few of blood
cells move through arteries and veins in that of 36 hpf
morphant embryos (Additional files 2). We also checked
the cardiac system, however, no obvious cardiac defect
was observed in the mtmr8 morphants (Additional files
3). Moreover, abnormal vasculogenesis was early
observed in mtmr8 morphant embryos of Tg(kdrl:GFP)
la116 transgenic zebrafish. As shown in Figure 3, when
Se sprouts have produced at 28 hpf and complete vascu-
lar system has formed at 36 hpf in Cont-MO embryos
(Figure 3A, C), the corresponding vascular structures
are absent or abnormal at the same stages in the mtmr8
morphant embryos (Figure 3B, D). The above data
further indicate that the vascular development defect
begins from the early stage, because the down-regulation
of multiple vascular marker genes for vasculogenesis has
been observed in the mtmr8 morphant embryos.
Expression defects of molecular marker genes for artery/
vein and vascular endothelium in mtmr8 morphants
To further reveal molecular expression defects, we firstly
used the endothelial cell marker fli1 to monitor the
effect of mtmr8 knockdown on vascular development.
As shown in Figure 4, in Cont-MO embryos, fli1 is
abundantly expressed in axial vasculature and Se sprouts
from the dorsal aorta at 26 hpf (Figure 4A), whereas in
mtmr8 morphants at the same stage, little fli1 transcript
is observed in the corresponding axial vasculature and
Se sprout regions (Figure 4B). The data indicates that
the endothelial-cell differentiation giving rise to the axial
vasculature is defective in mtmr8 morphants. As the
later-forming Se and new vessel growth were believed to
form respectively by sprouting and from preexisting ves-
sels[25], we next checked the formation of primary vas-
culature. The expression of ephrinB2a, an artery marker,
was detected in presumptive DA region of Cont-MO
embryos (Figure 4C). However, its expression was
severely reduced in the mtmr8 morphants (Figure 4D),
suggesting that the artery development should be
impaired. The expression of vein marker flt4 was
observed in PCV region of Cont-MO embryos (Figure
4E), whereas the flt4-positive PCV regions were
expanded, and its expression was partially reduced in
the mtmr8 morphants (Figure 4F). To confirm the role
of Mtmr8 in artery formation, we further examined the
expression changes of two Notch signaling markers
notch5 and grl/hey2. As shown in Figure 4G-J, signifi-
cant expression decrease of the two arterial marker
genes was observed in the mtmr8 morphants.
Moreover, the effects of mtmr8 knockdown on vascu-
logenesis were judged by endogenous alkaline phospha-
tase activity. In Cont-MO embryos (Figure 4K, L), the
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Figure 2 Mtmr8 knockdown results in vascular defects. (A-D) Vascular morphology in Cont-MO (A), mtmr8-MO (B), mtmr8-MO+ mtmr8
mRNA (C) and mtmr8-MO+dnPKA mRNA Tg(kdrl:GFP)la116 embryos at 48 hpf. The presumptive lumen of DA and PCV are indicated by red and
white bars, respectively. White arrowheads point to the interruption of Se. (E, F) Longitudinal sections of trunk regions in 48 hpf corresponding
embryos. (G-I) Transverse sections of trunk regions in 48 hpf corresponding embryos. Sections were stained with hematoxylin and eosin. (J)
Statistical data of three different defects in three independent experiments of Cont-MO, mtmr8-MO, mtmr8-MO+mtmr8 mRNA, mtmr8-MO+mis-
mtmr8 mRNA, mtmr8-MO+dnPKA mRNA, and mtmr8-MO+scl mRNA.
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endogenous alkaline phosphatase activity labeled the
major cerebral vessels and the subintestinal vessels
(SIVs). However, all Mtmr8 morphants displayed an
obvious reduction in the head signal and a total absence
of SIV labeling (Figure 4M, N). The obvious effects of
mtmr8 knockdown on endothelial cell alkaline
phosphatase activity further suggest that the vascular
changes should be specific to endothelial cells, and the
endothelial cell marker gene fli1 should be primary tar-
get for the mtmr8 functions.
Mtmr8 mediates PI3K/Akt signaling for artery
specification
In our previous study, mtmr8 knockdown was revealed
to activate the PI3K/Akt pathway[19]. To determine
whether the cooperation of Mtmr8 with PI3K plays a
role during vasculogenesis, we firstly assayed the affect
of PI3K inhibitor LY294002 on mtmr8 expression in
zebrafish embryos. As shown in Figure 5, compared
with control embryos (Figure 5A, E), lower concentra-
tion of LY294002 (10 and 25 μM) has no obvious effect
on mtmr8 expression in wild-type embryos (Figure 5B,
C, F, G), but significant increase expression of mtmr8
appears in the trunk vasculature when 50 μM LY294002
is used (Figure 5D, H). Figure 5I shows the quantitative
data from Q-RT-PCR.
In mtmr8 morphants, the expression of artery marker
gene ephrinB2a was severely reduced (Figure 4D) in the
trunk region, but the reduced levels were variable, and
might be classified into three kinds: normal, similar to
consistent expression in wild-type (Figure 5J), mild
defect, patchy expression in some cells along the DA
(Figure 5K), severe defect, almost no any ephrinB2a
expression in the trunk DA (Figure 5L). In previous stu-
dies[19], when treated with 10 μM LY294002, about half
of the mtmr8 morphants could be further deteriorated
in muscle development, and the others were mildly or
not obviously affected (Data not shown). However, 4
μM LY294002 had no obvious effect on the muscle phe-
notype of the morphants. Interestingly, when 4 μM
LY294002 was used to treat the mtmr8 morphants, a
significantly increasing proportion of normal embryos
was found in the morphants (Figure 5M). Subsequently,
we checked phosphorylation status of another early
arterial progenitor marker ERK (p42/44 MAP kinase)
[18] in the mtmr8 morphants by Western blot analysis,
and found that loss of Mtmr8 function significantly
reduces ERK phosphorylation (Figure 5N). The data
indicate that Mtmr8 negatively mediates PI3K/Akt sig-
naling for artery specification.
Mtmr8 is essential for normal vasculature development
through regulating Hedgehog and Vegf signaling
pathways
Hh signaling is multi-functional, and its role is tem-
poral-spatially determined during embryogenesis[26].
Shh from the notochord promotes Vegf expression by
the adjacent somite, which promotes expression of the
artery-specific EphrinB2 in the dorsal aorta[27]. To
determine the position of Mtmr8 in this regulatory
Figure 3 The effects of mtmr8 knockdown on early vasculature
development and blood formation in Tg(kdrl:GFP)la116
transgenic embryos. (A-D) Vascular morphology in Cont-MO (A, C)
and mtmr8-MO (B, D) Tg(kdrl:GFP)la116 transgenic embryos at 28 hpf
(A, B) and 36 hpf (C, D), respectively.
Figure 4 The effects of mtmr8 knockdown on vascular marker
genes and vascular endothelium. (A-J) Whole mount in situ
hybridization with the vascular marker gene-specific probes (as
shown on the left) in Cont-MO (A, C, E, G and I) and mtmr8-MO (B,
D, F, H and J) embryos at 26 hpf. The signals of DA, PCV and Se are
indicated by arrows, and the PCV expansion size is indicated by
double-arrowheads in the flt4 probe hybridization (E and F). (K-N)
Lateral (K, M) and dorsal (L, N) views of alkaline phosphatase-stained
Cont-MO (K, L) and mtmr8-MO (M, N) embryos at 3 dpf.
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Figure 5 Mtmr8 negatively regulates the PI3K/Akt pathway. (A-D) Mtmr8 expression in wild type (WT) embryo (A) and the treated embryos
(C-D) with different doses of LY294002 (LY) at 26 hpf. (E-H) The corresponding amplification of A-D, showing the detailed changes in the trunk
vasculature. (I) Mtmr8 expression changes revealed by Q-RT-PCR in embryos treated with different doses of LY294002 (μM). (J-L) Three
phenotypes of ephrinB2a expression and quantification data (M) in 26 hpf Mtmr8 morphants (30 embryos in each experiment group). (N)
Quantitative Western blot data of ERK phosphorylation in 20-somite Mtmr8 morphants. * Indicates significance of p < 0.05.
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cascade, we tested its expression in embryos when these
pathways were inhibited. As shown in Figure 6A and
6B, in 26 hpf wild-type embryos, ephrinB2a is absent in
the dorsal aorta when exposed to 50 μM cyclopamine,
and vegf expression is lost within the somites but per-
sisted within the hypochord (Data not shown, the result
same to Lawson et al[9]), which means that inhibition of
Hedgehog signaling can partially disrupt Vegf expres-
sion. Then, we investigated whether cyclopamine could
also inhibit the mtmr8 expression. As shown in Figure
6C-F, mtmr8 shows stronger expression in the posterior
cardinal vein than in the dorsal aorta of wild-type con-
trol embryos (Figure 6C-D), and its expression was
obviously upregulated in the cyclopamine-treated
embryos (Figure 6E-F). Figure 6K shows the gradient
up-regulation of mtmr8 under different doses of cyclo-
pamine obtained from Q-RT-PCR.
Vascular function is tightly regulated by Vegf signaling
pathway[28]. To assess whether Mtmr8 influenced the
developing vasculature through Vegf pathway, we trea-
ted 10 hpf embryos with a Vegf receptor tyrosine kinase
inhibitor, SU5416. In comparison with control embryos
(Figure 6G), the embryos incubated with 5 μM of
SU5416 failed to show vascular expression of mtmr8 in
the trunk at 30 hpf (Figure 6H), and the reduced tran-
script levels were detected under different doses of
SU5416 by Q-RT-PCR (Figure 6K), suggesting that
Mtmr8 might act downstream of Vegf to determine
arterial cell fate. Moreover, we checked the expression
of vegf165 in Mtmr8 morphants and control embryos,
and found a significant down-regulation of vegf165
expression within the somites at 26 hpf (Figure 6I, J),
and the quantitative down-regulation change was con-
firmed by Q-RT-PCR (Figure 6L).
In zebrafish, over-expression of either vegf121 or
vegf165 could rescue arterial differentiation blocked by a
deficiency of Shh signaling[9]. Direct activation of PKA,
an inhibitor of Hedgehog signaling, induces endothelial
cell apoptosis and inhibits angiogenesis in vivo, and sup-
pressing the PKA activity by expression of dnPKA, pro-
motes endothelial cell survival and migration during
angiogenesis[29,30]. Mtmr8 acts downstream of Vegf to
determine arterial cell fate, and its knockdown can
impair the Hedgehog signaling. On this basis, we further
assessed whether exogenous Vegf and Hedgehog signal-
ing were sufficient to rescue ephrinB2a expression in
the absence of mtmr8 activity. As shown in Figure 6M,
when injected with 100 pg dnPKA or vegf121+vegf 165
mRNA, the ephrinB2a expression in mtmr8 morphants
can be rescued as shown by reducing percentage of
embryos in the severe or mild defect group, which can
not be rescued by control GFP mRNA (Data not
shown). Moreover, we tested whether Vegf overexpres-
sion would lead to increase of mtmr8 expression. As
shown in Figure 7, when 100 pg vegf121+vegf 165
mRNA was injected, ptc1 expression is not affected (Fig-
ure 7A, B), but the expression of mtmr8 was up-regu-
lated (Figure 7C, D) (n = 17/28) in the injected
embryos. We therefore conclude that Mtmr8 expression
in vasculature is dependent on Vegf, and Mtmr8 is
essential for normal vasculature development through
regulating Hedgehog and Vegf signaling pathways.
Discussion
Previous studies have showed that mutations in most
myotubularin family genes are causative for human neuro-
muscular disorders[31]. And, knockdown of zebrafish
myotubularin and mtmr8 also impairs the embryo muscle
development[19,32]. Moreover, Mtmr8 has been shown to
negatively regulate the PI3K/AKT pathway[19]. In the
current study, we have further found that mtmr8 knock-
down leads to activation of PI3K/Akt signaling, which
impairs arterial endothelial marker gene expression, and
results in endothelial cell impairment and vasculogenesis
defects. Significantly, mtmr8 expression has been detected
in somitic and lateral mesoderm, where the angioblasts
are committed to endothelial lineage differentiation and
restricted to arterial or venous fate[19,33]. And, significant
expression reduction of endothelial progenitor marker
genes in mtmr8 morphants indicates that the impaired
arterial differentiation should be the consequence of
defects in endothelial cell formation. These results suggest
that mtmr8 should be essential for the endothelial cell dif-
ferentiation and vasculature development through repres-
sing the activity of PI3K in zebrafish.
Hedgehog signaling from notochord has been demon-
strated to promote somitic expression of Vegf, and
thereby to promote expression of the artery-specific
EphrinB2 in dorsal aorta[27]. Mtmr8 expression has
been detected in somitic and lateral mesoderm, where
angioblasts are restricted to arterial or venous fate, sug-
gesting that the impaired arterial differentiation in
mtmr8 morphants might be the consequence of defects
in Hedgehog/Vegf signaling pathways. And, the expres-
sion of mtmr8 is significantly repressed in the embryos
treated with inhibitor of Vegf signaling pathway (Figure
5G-H), suggesting that Mtmr8 might act downstream of
Vegf to determine arterial cell fate. The concomitant
down-regulation of ephrinB2a, ptc1 and vegf in Mtmr8
morphants raises the possibility that Mtmr8 acts
upstream of Hedgehog pathway. We hypothesize that
Mtmr8 regulates artery differentiation through two par-
allel ways (Figure 8). In one way, Mtmr8 may act down-
stream of Vegf. In other way, Mtmr8, Hedgehog and
Vegf may control artery specification through a regula-
tory loop (Figure 8). In normal physiological condition,
Mtmr8 is a downstream factor of Vegf signaling path-
way, and is partially regulated by the Hedgehog
Mei et al. BMC Developmental Biology 2010, 10:96
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Figure 6 (A-F) The expression of ephrinB2a (A, B) and mtmr8 (C-F) in 26 hpf embryos incubated with DMSO (A, C) or cyclopamine (B,
E). (D, F) are magnification of (C, E) in the trunk vasculture. (G-H) Mtmr8 expression in 30 hpf embryos incubated with DMSO (G) or SU5416 (H).
(I-J) Vegf165 expression in 26 hpf Cont-MO and Mtmr8 morphant embryos. (K) Mtmr8 expression changes revealed by Q-RT-PCR in embryos
treated with different doses of SU5416 and cyclopamine (μM). (L) Vegf165 expression in 26 hpf Cont-MO and Mtmr8 morphant embryos revealed
by Q-RT-PCR. (M) Statistical data of different defect phenotypes at 26 hpf in Mtmr8-MO, Mtmr8-MO+dnPKA mRNA, and Mtmr8-MO+vegf121/165
mRNA embryos.
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signaling pathway that is affected by the expression of
Mtmr8. Additionally, the down-expression of the hema-
tovascular progenitor marker genes hbae1 and fli1 in
mtmr8 morphants (Figure 1) suggests that mtmr8 might
also regulate hematovascular progenitor specification
and differentiation (Figure 8).
Conclusion
In conclusion, our findings indicate that Mtmr8 func-
tions as a key regulator of somitic muscle development
and vasculature development in zebrafish embryos. The
signaling pathways that function during vascular devel-
opment are highly conserved. Further analysis for
Mtmr8 function will be essential to understand the
complex signaling hierarchy for the differentiation of
endothelial cells and the development of vasculature in
vertebrates.
Methods
Zebrafish husbandry
Danio rerio wild-type (WT) AB strain, and Tg(kdrl:GFP)
la116 transgenic zebrafish (previous Tg(flk1:GFP)la116)
[23] were used. Zebrafish were maintained and staged as
described[34]. When necessary, embryos were anesthe-
tized with 0.003% tricaine (Sigma). All of the experimen-
tal researches on zebrafish were performed with the
approval of the animal ethics committee in the Institute
of Hydrobiology, Chinese Academy of Sciences.
Antisense morpholino and mRNA microinjection
The sequences and doses of the injected morpholinos
were described previously[19]. mtmr8, dnPKA, scl,
vegf121 and vegf165 cDNAs were subcloned into PCS2+
plasmid for in vitro synthesis of capped mRNA, using
SP6 RNA polymerase (Ambion), following the manufac-
turer’s instructions. A mis-matched mtmr8 mRNA (mis-
mtmr8) was constructed by using mis-match forward
prime 5’-ATGGAGCACATCATAACGCCCAAAGTCG-
3’ (underlines indicate the changed nucleotide). All
mRNA were re-suspended in water and co-injected at a
concentration of 50-100 ng/μL.
Whole-mount in situ hybridization, endogenous alkaline
phosphatase-based vessel staining and histological
analysis
Embryos at different stages were collected and fixed as
described[35]. Purified plasmids were linearized by
selected restriction enzymes and used as templates for
in vitro transcription using T7 or Sp6 RNA polymerase
to generate DIG-labeled (Roche) sense and anti-sense
probes. Whole mount in situ hybridization was per-
formed as described previously[36,37].
At 72 hpf, embryos were fixed in 4% paraformaldehyde
and dehydrated in methanol. Later, they were rehydrated
to PBST and then used for staining, as described by Ser-
bedzija et al [38]. Histological analysis was performed
according to methods described by Lawson et al [17].
Real-time quantitative PCR (Q-RT-PCR) and Western blot
detection
Real-time quantitative PCR was performed by DNA
Engine Chromo 4 Real-Time System (MJ Research) with
SYBR Green I Dye according to a previous report[39].
The ratio of these genes to b-actin in control embryos
was set to 1 (100%), and the expression of all morpho-
lino-injected or drug-treated embryos were normalized
relative to this value. All samples were analyzed in tripli-
cates and the results were expressed relative to the
expression of b-actin using the 2 (-delta delta C(T))
method [40]. Data are presented as mean ± SD of three
separate experiments.
Figure 7 The effect of Vegf overexpression on mtmr8
expression. (A, B) Expression of ptc1 in wild type (WT) embryo (A)
and in vegf121/165 mRNA injected embryo (B). (C, D) Expression of
mtmr8 in wild type (WT) embryo (C) and in vegf121/165 mRNA
injected embryo (D). All embryos in 25 hpf; anterior toward the left.
Figure 8 A hypothesized signal pathway that Mtmr8 regulates
artery specification and hematovascular progenitor
specification in zebrafish embryo. Mtmr8 inhibits PI3K/Akt
pathway, and activates Hh and Vegf signaling pathway, which may
interact with each other in regulating vasculature development. The
pink arrows indicate the regulatory loop.
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Western blot detection for the ratio between phospho-
p44/42 MAP kinase (Thr202/Tyr204) and p44/42 MAP
kinase in developing zebrafish larvae was performed
essentially as described[18]. The membranes were
washed and incubated with Alkaline Phosphatase (AP)-
conjugated secondary antibodies. Images of blots were
captured with a scanner, and quantitative densitometric
analysis was performed using Scion Image.
Drug treatments
PI3K inhibitor, LY294002 (Promega) was dissolved in
DMSO at stock concentration of 50 mM. For experi-
ments, embryos were incubated in embryo media con-
taining 0-50 μM of the drug from 10 hpf to 24 hpf.
Control embryos were treated with the equivalent
amount of DMSO solution (1%≤).
Cyclopamine and SU5416 were obtained from Cal-
biochem and were used at a concentration of 0-50 μm
and 0-5 μM respectively. Zebrafish embryos were
soaked in 6-well plates and were treated with the
drugs from 10 hpf, until they were processed for in
situ experiments. Control embryos were treated in
embryo medium containing equivalent amount of
DMSO solution (1% < ).
Statistical analysis
All the experiments were performed in triplicates (about
30 embryos in each experiment group). Data were pre-
sented as mean ± SD. The data in morphant embryos
compared to the control (set to 1) were assessed by
one-way analysis of variance (ANOVA), followed by the
Tukey’s post hoc test for multiple comparisons. A prob-
ability (*P) of <0.05 was considered statistically
significant.
Additional material
Additional file 1: The effects of mtmr8 knockdown on circulation of
embryos at 28 hpf. Movie showing circulation in trunk of a Cont-MO
injected embryo (left side) and loss of circulation in trunk of a mtmr8
morphant embryo at the same stage (right side). Anterior is to the up.
Additional file 2: The effects of mtmr8 knockdown on circulation of
embryos at 36 hpf. Movie showing circulation in trunk of a Cont-MO
injected embryo (left side) and loss of circulation in trunk of a mtmr8
morphant embryo at the same stage (right side). Anterior is to the up.
Additional file 3: The effects of mtmr8 knockdown on heart
contractions of embryos at 48 hpf. Movie showing heart contractions
of a Cont-MO injected embryo (left side) and a mtmr8 morphant embryo
at the same stage (right side).
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